Impaired Ribosome Biogenesis and P53 Activation in Haematological Disease: Novel Therapeutic Strategies

Journal of Bone Marrow Research
doi 10.4172/2329-8820.1000121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Kri1l: A Novel Gene That Links Defective Ribosome Biogenesis to Impaired Hematopoiesis Through Excessive Autophagy

Science Bulletin
Multidisciplinary
2015English

Advances in Developing Novel Therapeutic Strategies for Alzheimer’s Disease

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2018English

Cardiovascular Manifestations of Fabry Disease and the Novel Therapeutic Strategies

Journal of Nippon Medical School
Medicine
2005English

MicroRNAs and Long Non-Coding RNAs as Novel Regulators of Ribosome Biogenesis

Biochemical Society Transactions
Biochemistry
2020English

The Pre-Existing Population of 5S rRNA Effects P53 Stabilization During Ribosome Biogenesis Inhibition

Oncotarget
Oncology
2016English

Diamond Blackfan Anemia and Ribosome Biogenesis: Introduction

Seminars in Hematology
Hematology
2011English

Ribosome Biogenesis in the Yeast Saccharomyces Cerevisiae

Genetics
Genetics
2013English

Inhibition of Post-Transcriptional Steps in Ribosome Biogenesis Confers Cytoprotection Against Chemotherapeutic Agents in a P53-Dependent Manner

Scientific Reports
Multidisciplinary
2017English

Ribosomal DNA-connecting Ribosome Biogenesis and Chromosome Biology

Chromosome Research
Genetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy